The efficiency of specific immunization with corpuscular vaccines in the treatment and prophylaxis of Pseudomonas aeruginosa infections of the bones.
D000293:Adolescent; D000328:Adult; D000368:Aged; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001428:Bacterial Vaccines / Q000276:immunology / Q000627:therapeutic use*; D001847:Bone Diseases / Q000276:immunology / Q000517:prevention & control / Q000628:therapy*; D004341:Drug Evaluation; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011552:Pseudomonas Infections / Q000276:immunology / Q000517:prevention & control / Q000628:therapy*; D011550:Pseudomonas aeruginosa / Q000276:immunology*
D000900:Anti-Bacterial Agents; D001428:Bacterial Vaccines